Glanzmann Thrombasthenia clinical trials

Explore recruiting glanzmann thrombasthenia clinical trials.

Recruiting glanzmann thrombasthenia studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Glanzmann Thrombasthenia trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

A Phase 1/2, First-in-Human, Single and Multiple Ascending Dose Study to Investigate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Efficacy of HMB-001 in Participants With Glanzmann Thrombasthenia

Netherlands, Italy, Belgium, France

Phase I and Phase II (Integrated)- First administration to humans EU CTIS Study details

Glanzmann Thrombasthenia trials by city

Glanzmann Thrombasthenia in Toronto Glanzmann Thrombasthenia in Vancouver Glanzmann Thrombasthenia in Montreal Glanzmann Thrombasthenia in Calgary Glanzmann Thrombasthenia in Edmonton Glanzmann Thrombasthenia in Ottawa Glanzmann Thrombasthenia in Winnipeg Glanzmann Thrombasthenia in Quebec City Glanzmann Thrombasthenia in Hamilton Glanzmann Thrombasthenia in Kitchener Glanzmann Thrombasthenia in London Glanzmann Thrombasthenia in Halifax Glanzmann Thrombasthenia in New York Glanzmann Thrombasthenia in Los Angeles Glanzmann Thrombasthenia in Chicago Glanzmann Thrombasthenia in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease